{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:55Z","timestamp":1792014415289,"version":"4.4.0"},"reference-count":118,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100007943","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012781","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer-Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015371","name":"ReCor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Germany Ministry of Research and Education"},{"name":"Bavaria Nordisk"},{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Influenza, pneumococcal, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus infections are important causes of high morbidity and mortality in the elderly. Beyond the burden of infectious diseases, they are also associated with several non-infectious complications like cardiovascular events. A growing body of evidence in prospective studies and meta-analyses has shown the impact of influenza and pneumococcal vaccines on types of cardiovascular outcomes in the general population. Influenza vaccination showed a potential benefit for primary and secondary prevention of cardiovascular diseases across all ages. A reduced risk of cardiovascular events for individuals aged 65 years and older was associated with pneumococcal vaccination. Despite scientific evidence on the effectiveness, safety, and benefits of the vaccines and recommendations to vaccinate elderly patients and those with risk factors, vaccination rates remain sub-optimal in this population. Doubts about vaccine necessity or efficacy and concerns about possible adverse events in patients and physicians refer to delayed acceptance. Vaccination campaigns targeting increasing professional recommendations and public perceptions should be implemented in the coming years. The aim of this review paper is to summarize the effect of vaccination in the field of cardiovascular disease to achieve a higher vaccination rate in this patient population.<\/jats:p>","DOI":"10.1093\/eurjpc\/zwae016","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:47:23Z","timestamp":1704984443000},"page":"877-888","source":"Crossref","is-referenced-by-count":36,"title":["Association of respiratory infections and the impact of vaccinations on cardiovascular diseases"],"prefix":"10.1093","volume":"31","author":[{"given":"Jessica","family":"Rademacher","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Hannover Medical School , Carl-Neuberg-Str. 1, Hannover 30625 , Germany"},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Therre","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Universit\u00e4tsklinikum des Saarlandes, Saarland University , Kirrberger Str. 1, Homburg 66421 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Alexander","family":"Hinze","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Hannover Medical School , Carl-Neuberg-Str. 1, Hannover 30625 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Buder","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Universit\u00e4tsklinikum des Saarlandes, Saarland University , Kirrberger Str. 1, Homburg 66421 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-2514","authenticated-orcid":false,"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Universit\u00e4tsklinikum des Saarlandes, Saarland University , Kirrberger Str. 1, Homburg 66421 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-7356","authenticated-orcid":false,"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Hannover Medical School , Carl-Neuberg-Str. 1, Hannover 30625 , Germany"},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2024051107395404700_zwae016-B1","author":"World Health Organization"},{"key":"2024051107395404700_zwae016-B2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/oxfordjournals.aje.a112007","article-title":"Excess mortality from epidemic influenza, 1957\u20131966","volume":"100","author":"Housworth","year":"1974","journal-title":"Am J Epidemiol"},{"key":"2024051107395404700_zwae016-B3","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jir171","article-title":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong","volume":"203","author":"Warren-Gash","year":"2011","journal-title":"J Infect Dis"},{"key":"2024051107395404700_zwae016-B4","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"key":"2024051107395404700_zwae016-B5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(97)11084-4","article-title":"Acute respiratory-tract infections and risk of first-time acute myocardial infarction","volume":"351","author":"Meier","year":"1998","journal-title":"Lancet"},{"key":"2024051107395404700_zwae016-B7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s100960000376","article-title":"Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom","volume":"19","author":"Meier","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024051107395404700_zwae016-B8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024051107395404700_zwae016-B9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/14779072.2015.1044439","article-title":"Does influenza vaccination influence cardiovascular complications?","volume":"13","author":"Udell","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2024051107395404700_zwae016-B10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1134\/S0006297916110134","article-title":"The role of cytokines in the development of atherosclerosis","volume":"81","author":"Fatkhullina","year":"2016","journal-title":"Biochem Mosc"},{"key":"2024051107395404700_zwae016-B11","doi-asserted-by":"crossref","first-page":"570681","DOI":"10.3389\/fimmu.2020.570681","article-title":"Immune mechanisms in cardiovascular diseases associated with viral infection","volume":"11","author":"Gopal","year":"2020","journal-title":"Front Immunol"},{"key":"2024051107395404700_zwae016-B12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.CIR.0000048190.68071.2B","article-title":"Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E\u2013deficient mice","volume":"107","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"2024051107395404700_zwae016-B13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/cvr\/cvaa117","article-title":"Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death","volume":"117","author":"Filgueiras-Rama","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2024051107395404700_zwae016-B14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcrc.2013.01.010","article-title":"Myocardial dysfunction during H1N1 influenza infection","volume":"28","author":"Fagnoul","year":"2013","journal-title":"J Crit Care"},{"key":"2024051107395404700_zwae016-B15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cvr\/cvq358","article-title":"Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis","volume":"89","author":"Pan","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2024051107395404700_zwae016-B16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s44161-022-00096-8","article-title":"Hyperactivity of the CD155 immune checkpoint suppresses anti-viral immunity in patients with coronary artery disease","volume":"1","author":"Zhao","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"2024051107395404700_zwae016-B17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2011.03.019","article-title":"Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice","volume":"217","author":"Berm\u00fadez-Fajardo","year":"2011","journal-title":"Atherosclerosis"},{"key":"2024051107395404700_zwae016-B18","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1016\/j.vaccine.2014.07.007","article-title":"Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism","volume":"32","author":"Veljkovic","year":"2014","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacbts.2020.04.002","article-title":"COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies","volume":"5","author":"Atri","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2024051107395404700_zwae016-B20","doi-asserted-by":"crossref","first-page":"200258","DOI":"10.1183\/16000617.0258-2020","article-title":"Influenza vaccination: protecting the most vulnerable","volume":"30","author":"Tanner","year":"2021","journal-title":"Eur Respir Rev"},{"key":"2024051107395404700_zwae016-B21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/v13060971","article-title":"Selecting and using the appropriate influenza vaccine for each individual","volume":"13","author":"Sekiya","year":"2021","journal-title":"Viruses"},{"key":"2024051107395404700_zwae016-B22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/eurheartj\/ehac826","article-title":"The ideal vaccine to prevent cardiovascular disease","volume":"44","author":"Fr\u00f6bert","year":"2023","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2024051107395404700_zwae016-B24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jchf.2015.10.012","article-title":"Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial","volume":"4","author":"Vardeny","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2024051107395404700_zwae016-B25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ejhf.14","article-title":"Influenza vaccine and survival in acute heart failure","volume":"16","author":"Kopel","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2024051107395404700_zwae016-B26","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s11606-021-07068-x","article-title":"Influenza vaccination and mortality among adults with heart failure in an integrated healthcare delivery system, 2009\u20132018","volume":"37","author":"Mefford","year":"2022","journal-title":"J Gen Intern Med"},{"key":"2024051107395404700_zwae016-B27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.amjcard.2020.05.019","article-title":"Influenza vaccination and outcome in heart failure","volume":"128","author":"Gotsman","year":"2020","journal-title":"Am J Cardiol"},{"key":"2024051107395404700_zwae016-B28","first-page":"350","article-title":"Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies","volume":"106","author":"Rodrigues","year":"2020","journal-title":"Heart Br Card Soc"},{"key":"2024051107395404700_zwae016-B29","doi-asserted-by":"crossref","first-page":"20235","DOI":"10.1038\/s41598-023-47690-9","article-title":"Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies","volume":"13","author":"Omidi","year":"2023","journal-title":"Sci Rep"},{"key":"2024051107395404700_zwae016-B30","first-page":"1039","article-title":"Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study","volume":"108","author":"de Abajo","year":"2022","journal-title":"Heart Br Card Soc"},{"key":"2024051107395404700_zwae016-B31","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1503\/cmaj.091891","article-title":"Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study","volume":"182","author":"Siriwardena","year":"2010","journal-title":"CMAJ Can Med Assoc"},{"key":"2024051107395404700_zwae016-B32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ahj.2022.10.005","article-title":"Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction\u2014insights from the IAMI trial","volume":"255","author":"Fr\u00f6bert","year":"2023","journal-title":"Am Heart J"},{"key":"2024051107395404700_zwae016-B33","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/01.CIR.102.25.3039","article-title":"Association of influenza vaccination and reduced risk of recurrent myocardial infarction","volume":"102","author":"Naghavi","year":"2000","journal-title":"Circulation"},{"key":"2024051107395404700_zwae016-B34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B35","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.CIR.0000016182.85461.F4","article-title":"Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU vaccination acute coronary syndromes (FLUVACS) study","volume":"105","author":"Gurfinkel","year":"2002","journal-title":"Circulation"},{"key":"2024051107395404700_zwae016-B36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B37","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B38","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11886-022-01748-8","article-title":"Influenza vaccination for cardiovascular prevention: further insights from the IAMI trial and an updated meta-analysis","volume":"24","author":"Maniar","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2024051107395404700_zwae016-B39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2020.23649","article-title":"Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: a randomized clinical trial","volume":"325","author":"Vardeny","year":"2021","journal-title":"JAMA"},{"key":"2024051107395404700_zwae016-B40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/eurheartj\/ehac737","article-title":"Primary prevention of acute cardiovascular events by influenza vaccination: an observational study","volume":"44","author":"Davidson","year":"2023","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B41","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1007\/s11357-023-00807-4","article-title":"Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review","volume":"45","author":"Addario","year":"2023","journal-title":"GeroScience"},{"key":"2024051107395404700_zwae016-B42","doi-asserted-by":"crossref","first-page":"e0207918","DOI":"10.1371\/journal.pone.0207918","article-title":"Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: analysis by dominant viral subtype and vaccine matching","volume":"13","author":"Song","year":"2018","journal-title":"PLoS One"},{"key":"2024051107395404700_zwae016-B43","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2024051107395404700_zwae016-B44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ypmed.2012.03.020","article-title":"Effects of annual influenza vaccination on mortality and hospitalization in elderly patients with ischemic heart disease: a nationwide population-based study","volume":"54","author":"Liu","year":"2012","journal-title":"Prev Med"},{"key":"2024051107395404700_zwae016-B45","first-page":"204","article-title":"The protective effect of pneumococcal vaccination on cardiovascular disease in adults: a systematic review and meta-analysis","volume":"99","author":"Marra","year":"2020","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"2024051107395404700_zwae016-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2017.07.020","article-title":"Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients","volume":"193","author":"Chiang","year":"2017","journal-title":"Am Heart J"},{"key":"2024051107395404700_zwae016-B47","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.vaccine.2023.02.077","article-title":"Association of pneumococcal vaccination with cardiovascular diseases in older adults: the vaccine effectiveness, networking, and universal safety (VENUS) study","volume":"41","author":"Narii","year":"2023","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cmpb.2013.05.006","article-title":"Influenza vaccination and reduction in risk of ischemic heart disease among chronic obstructive pulmonary elderly","volume":"111","author":"Huang","year":"2013","journal-title":"Comput Methods Programs Biomed"},{"key":"2024051107395404700_zwae016-B49","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJM199409223311206","article-title":"The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community","volume":"331","author":"Nichol","year":"1994","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B50","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/656587","article-title":"Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study","volume":"51","author":"Hung","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024051107395404700_zwae016-B51","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.vaccine.2014.04.064","article-title":"Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study","volume":"32","author":"Sung","year":"2014","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B52","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1053\/j.ajkd.2019.09.008","article-title":"Effectiveness of influenza vaccination among older adults across kidney function: pooled analysis of 2005\u20132006 through 2014\u20132015 influenza seasons","volume":"75","author":"Ishigami","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2024051107395404700_zwae016-B53","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.hrthm.2016.01.026","article-title":"The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study","volume":"13","author":"Chang","year":"2016","journal-title":"Heart Rhythm"},{"key":"2024051107395404700_zwae016-B54","doi-asserted-by":"crossref","first-page":"e0219172","DOI":"10.1371\/journal.pone.0219172","article-title":"Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders\u2014a propensity score-matched follow-up study","volume":"14","author":"Wu","year":"2019","journal-title":"PLoS One"},{"key":"2024051107395404700_zwae016-B55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jinf.2012.04.014","article-title":"Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan\u2013a representative population-based comparative study","volume":"65","author":"Chang","year":"2012","journal-title":"J Infect"},{"key":"2024051107395404700_zwae016-B56","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","article-title":"Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial","volume":"10","author":"Loeb","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2024051107395404700_zwae016-B57","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1016\/S0264-410X(03)00296-2","article-title":"Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up","volume":"21","author":"Hedlund","year":"2003","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B58","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1212\/WNL.0000000000000456","article-title":"Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke","volume":"82","author":"Lavall\u00e9e","year":"2014","journal-title":"Neurology"},{"key":"2024051107395404700_zwae016-B59","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jacc.2006.09.004","article-title":"Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association\/American College of Cardiology","volume":"48","author":"Davis","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2024051107395404700_zwae016-B60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2020\u201321 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2024051107395404700_zwae016-B61","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2024051107395404700_zwae016-B62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1469-0691.2010.03296.x","article-title":"Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population","volume":"17","author":"Bruns","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2024051107395404700_zwae016-B63","doi-asserted-by":"crossref","first-page":"9696","DOI":"10.1038\/s41598-021-89038-1","article-title":"Hospitalization for acute coronary syndrome increases the long-term risk of pneumonia: a population-based cohort study","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"2024051107395404700_zwae016-B64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1183\/09031936.00049111","article-title":"Is community-acquired pneumonia an independent risk factor for cardiovascular disease?","volume":"39","author":"Singanayagam","year":"2012","journal-title":"Eur Respir J"},{"key":"2024051107395404700_zwae016-B65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/resp.13233","article-title":"Pneumonia as a cardiovascular disease","volume":"23","author":"Restrepo","year":"2018","journal-title":"Respirol Carlton Vic"},{"key":"2024051107395404700_zwae016-B66","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.3390\/jcm12072577","article-title":"Acute coronary syndrome, stroke, and mortality after community-acquired pneumonia: systematic review and meta-analysis","volume":"12","author":"Meregildo-Rodriguez","year":"2023","journal-title":"J Clin Med"},{"key":"2024051107395404700_zwae016-B67","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J Infect Dis"},{"key":"2024051107395404700_zwae016-B68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2024051107395404700_zwae016-B69","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B70","doi-asserted-by":"crossref","first-page":"2168354","DOI":"10.1080\/20018525.2023.2168354","article-title":"Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis","volume":"10","author":"Sikj\u00e6r","year":"2023","journal-title":"Eur Clin Respir J"},{"key":"2024051107395404700_zwae016-B71","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/infdis\/jiab474","article-title":"Effectiveness of pneumococcal vaccination against pneumococcal pneumonia hospitalization in older adults: a prospective, test-negative study","volume":"225","author":"Heo","year":"2022","journal-title":"J Infect Dis"},{"key":"2024051107395404700_zwae016-B72","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14760584.2019.1688149","article-title":"Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD)","volume":"18","author":"Tin Tin Htar","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2024051107395404700_zwae016-B73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after Introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe","volume":"28","author":"Hanquet","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2024051107395404700_zwae016-B74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024051107395404700_zwae016-B75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciab990","article-title":"Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged \u226518 years","volume":"75","author":"Essink","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024051107395404700_zwae016-B76","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.vaccine.2021.07.004","article-title":"A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age","volume":"39","author":"Klein","year":"2021","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B77","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1016\/j.vaccine.2021.10.032","article-title":"A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults \u226565 years of age with different prior pneumococcal vaccination","volume":"39","author":"Cannon","year":"2021","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40560-020-00508-6","article-title":"Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a systematic review and meta-analysis","volume":"8","author":"Zhao","year":"2020","journal-title":"J Intensive Care"},{"key":"2024051107395404700_zwae016-B79","first-page":"e18","article-title":"Cardiac complications and pertaining mortality rate in COVID-19 patients; a systematic review and meta-analysis","volume":"9","author":"Toloui","year":"2021","journal-title":"Arch Acad Emerg Med"},{"key":"2024051107395404700_zwae016-B80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10456-022-09860-7","article-title":"Inflammation and vascular remodeling in COVID-19 hearts","volume":"26","author":"Werlein","year":"2023","journal-title":"Angiogenesis"},{"key":"2024051107395404700_zwae016-B81","author":"CDC"},{"key":"2024051107395404700_zwae016-B82"},{"key":"2024051107395404700_zwae016-B83","author":"CDC"},{"key":"2024051107395404700_zwae016-B84","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacc.2022.12.006","article-title":"Impact of vaccination on major adverse cardiovascular events in patients with COVID-19 infection","volume":"81","author":"Jiang","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2024051107395404700_zwae016-B85","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2022.12992","article-title":"Association between vaccination and acute myocardial infarction and ischemic stroke after COVID-19 infection","volume":"328","author":"Kim","year":"2022","journal-title":"JAMA"},{"key":"2024051107395404700_zwae016-B86","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B87","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military","volume":"6","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2024051107395404700_zwae016-B88","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","article-title":"Respiratory syncytial virus and associations with cardiovascular disease in adults","volume":"71","author":"Ivey","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024051107395404700_zwae016-B89","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","article-title":"Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"key":"2024051107395404700_zwae016-B90","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/ciab595","article-title":"Incidence of respiratory syncytial virus infection among hospitalized adults, 2017\u20132020","volume":"74","author":"Branche","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024051107395404700_zwae016-B91","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1164\/ajrccm.160.3.9901004","article-title":"Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease","volume":"160","author":"Walsh","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051107395404700_zwae016-B92","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.vaccine.2006.09.041","article-title":"Influenza- and RSV-associated hospitalizations among adults","volume":"25","author":"Mullooly","year":"2007","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12879-015-1218-z","article-title":"Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom","volume":"15","author":"Fleming","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2024051107395404700_zwae016-B94","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12879-014-0665-2","article-title":"Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study","volume":"14","author":"Volling","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2024051107395404700_zwae016-B95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cmi.2016.11.014","article-title":"Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France","volume":"23","author":"Loubet","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2024051107395404700_zwae016-B96","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/605948","article-title":"Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults","volume":"200","author":"Duncan","year":"2009","journal-title":"J Infect Dis"},{"key":"2024051107395404700_zwae016-B97","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B98","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B99","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines9060624","article-title":"Considerations for a respiratory syncytial virus vaccine targeting an elderly population","volume":"9","author":"Stephens","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2024051107395404700_zwae016-B100","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024051107395404700_zwae016-B101","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B102","first-page":"jiad321","article-title":"Safety and immunogenicity of a revaccination with a respiratory syncytial virus prefusion F vaccine in older adults: a phase 2b study","author":"Leroux-Roels","year":"2023","journal-title":"J Infect Dis"},{"key":"2024051107395404700_zwae016-B103","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"2024051107395404700_zwae016-B104","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/eurheartj\/ehad005","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"44","author":"Humbert","year":"2023","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2024051107395404700_zwae016-B106","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B107","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B108","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B109","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B110","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO): the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B112","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2024051107395404700_zwae016-B115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.puhe.2023.10.028","article-title":"Trends in influenza vaccine uptake before and during the COVID-19 pandemic in the USA","volume":"225","author":"Lin","year":"2023","journal-title":"Public Health"},{"key":"2024051107395404700_zwae016-B116","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1016\/j.vaccine.2022.10.090","article-title":"Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation","volume":"40","author":"Kpozehouen","year":"2022","journal-title":"Vaccine"},{"key":"2024051107395404700_zwae016-B117","doi-asserted-by":"crossref","first-page":"2252250","DOI":"10.1080\/21645515.2023.2252250","article-title":"Influenza vaccination landscape in Italy: a comprehensive study through the OBVIOUS project lens","volume":"19","author":"Capodici","year":"2023","journal-title":"Hum Vaccines Immunother"},{"key":"2024051107395404700_zwae016-B118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.puhe.2023.09.002","article-title":"Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece","volume":"224","author":"Tsiligianni","year":"2023","journal-title":"Public Health"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae016\/56410335\/zwae016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/7\/877\/57519887\/zwae016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/7\/877\/57519887\/zwae016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T07:41:39Z","timestamp":1715413299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/31\/7\/877\/7516103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":118,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,5,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae016","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,1,11]]}}}